HCV - Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership

Inovio Biomedical to Develop Vaccine for Hepatitis C in Partnership
Genetic Engineering News - Inovio Biomedical Corporation (AMEX:INO), a late stage developer of cancer and other therapies using electroporation to deliver drugs and nucleic acids, announced today that it has signed an agreement with Swedish-based Tripep AB (The Stockholm

Hepatitis C treatment difficult in older patients
New Kerala - NEW YORK: Because of side effects, patients over the age of 60 with hepatitis C find it more difficult to stick with standard treatments than do their younger counterparts, according to a study in Japan. Impaired heart, lung and kidney function can

AVI BioPharma's NEUGENE Shows Success Against Deadly Ebola Virus
Genetic Engineering News - AVI BioPharma, Inc. (Nasdaq:AVII), today announced publication of significant research carried out in collaboration with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The report, published today in Public Library of

Organ Donor Rates for 2005 Worst Ever
Scoop - Organ Donor Rates for 2005 Worst Ever. Figures released today show that New Zealand has hit an all time low in the number of organ donors it has. Just 29 people became organ donors in 2005. The previous lowest was 34 donors, more than 16 years ago